These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression. Koike H; Fukumoto K; Iijima M; Chaki S Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797 [TBL] [Abstract][Full Text] [Related]
4. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression. Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193 [TBL] [Abstract][Full Text] [Related]
5. Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling. Qu Y; Shan J; Wang S; Chang L; Pu Y; Wang X; Tan Y; Yamamoto M; Hashimoto K Eur Arch Psychiatry Clin Neurosci; 2021 Apr; 271(3):439-446. PubMed ID: 33180200 [TBL] [Abstract][Full Text] [Related]
6. Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine. Dong C; Zhang JC; Yao W; Ren Q; Ma M; Yang C; Chaki S; Hashimoto K Int J Neuropsychopharmacol; 2017 Mar; 20(3):228-236. PubMed ID: 27765808 [TBL] [Abstract][Full Text] [Related]
7. Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling. Wei Y; Chang L; Hashimoto K Eur Neuropsychopharmacol; 2021 Sep; 50():55-63. PubMed ID: 33971385 [TBL] [Abstract][Full Text] [Related]
8. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression. Zhang JC; Yao W; Dong C; Yang C; Ren Q; Ma M; Han M; Hashimoto K Psychopharmacology (Berl); 2015 Dec; 232(23):4325-35. PubMed ID: 26337614 [TBL] [Abstract][Full Text] [Related]
9. Two standardized fractions of Gardenia jasminoides Ellis with rapid antidepressant effects are differentially associated with BDNF up-regulation in the hippocampus. Ren L; Tao W; Zhang H; Xue W; Tang J; Wu R; Xia B; Wu H; Chen G J Ethnopharmacol; 2016 Jul; 187():66-73. PubMed ID: 27108051 [TBL] [Abstract][Full Text] [Related]
10. Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine. Xiong Z; Zhang K; Ishima T; Ren Q; Ma M; Pu Y; Chang L; Chen J; Hashimoto K Pharmacol Biochem Behav; 2019 Jan; 176():57-62. PubMed ID: 30502360 [TBL] [Abstract][Full Text] [Related]
11. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress. Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109 [TBL] [Abstract][Full Text] [Related]
12. VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy. Nickols HH; Yuh JP; Gregory KJ; Morrison RD; Bates BS; Stauffer SR; Emmitte KA; Bubser M; Peng W; Nedelcovych MT; Thompson A; Lv X; Xiang Z; Daniels JS; Niswender CM; Lindsley CW; Jones CK; Conn PJ J Pharmacol Exp Ther; 2016 Jan; 356(1):123-36. PubMed ID: 26503377 [TBL] [Abstract][Full Text] [Related]
13. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression. Koike H; Iijima M; Chaki S Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235 [TBL] [Abstract][Full Text] [Related]
14. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice. Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718 [TBL] [Abstract][Full Text] [Related]
15. Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors. Nowak G; Pomierny-Chamioło L; Siwek A; Niedzielska E; Pomierny B; Pałucha-Poniewiera A; Pilc A Neuropharmacology; 2014 Sep; 84():46-51. PubMed ID: 24796254 [TBL] [Abstract][Full Text] [Related]
16. Subchronic administration of scopolamine reverses UCMS-induced behavior in mice via eEF2 protein dephosphorylation. Babii Y; Pałucha-Poniewiera A; Rafało-Ulińska A; Brański P; Pilc A Pharmacol Rep; 2024 Oct; 76(5):1001-1011. PubMed ID: 39042346 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms for the antidepressant-like effects of a low-dose ketamine treatment in a DFP-based rat model for Gulf War Illness. Ribeiro ACR; Zhu J; Kronfol MM; Jahr FM; Younis RM; Hawkins E; McClay JL; Deshpande LS Neurotoxicology; 2020 Sep; 80():52-59. PubMed ID: 32592718 [TBL] [Abstract][Full Text] [Related]
20. Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology. Sengmany K; Hellyer SD; Albold S; Wang T; Conn PJ; May LT; Christopoulos A; Leach K; Gregory KJ Neuropharmacology; 2019 May; 149():83-96. PubMed ID: 30763654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]